(Q46212623)

20 December 2017

title

The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage (English)

1 reference

20 December 2017

1 reference

Komuro H

1

1 reference

20 December 2017

Olee T

2

1 reference

20 December 2017

Kühn K

3

1 reference

20 December 2017

Quach J

4

1 reference

20 December 2017

Brinson DC

5

1 reference

20 December 2017

Shikhman A

6

1 reference

20 December 2017

Valbracht J

7

1 reference

20 December 2017

Creighton-Achermann L

8

1 reference

20 December 2017

Lotz M

9

1 reference

20 December 2017

publication date

1 December 2001

1 reference

20 December 2017

published in

Arthritis & Rheumatology

1 reference

20 December 2017

volume

44

1 reference

20 December 2017

issue

12

1 reference

20 December 2017

page(s)

2768-2776

1 reference

20 December 2017

The role of the chondrocyte in osteoarthritis

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Osteoprotegerin ligand: a regulator of immune responses and bone physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Abnormal cancellous bone collagen metabolism in osteoarthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

Prediction of the progression of joint space narrowing in osteoarthritis of the knee by bone scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1529-0131%28200112%2944%3A12%3C2768%3A%3AAID-ART464%3E3.0.CO%3B2-I

10.1002/1529-0131(200112)44:12<2768::AID-ART464>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017